Inovio Pharmaceuticals, Inc.
NASDAQ:INO
5.15 (USD) • At close November 12, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 0.832 | 10.262 | 1.775 | 7.411 | 4.112 | 30.482 | 42.22 | 35.368 | 40.572 | 10.457 | 13.467 | 4.119 | 9.795 | 6.145 | 9.12 | 2.098 | 4.808 | 3.468 | 5.467 | 1.167 | 0.081 | 0.19 | 4.453 | 5.077 | 8.3 |
| Cost of Revenue
| 3.504 | 5.496 | 4.731 | 94.245 | 88.017 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.225 | 0.206 | 0 | 0 | 0 | 1.925 | 1.458 | 1.2 |
| Gross Profit
| -2.672 | 4.766 | -2.956 | -86.834 | -83.905 | 30.482 | 42.22 | 35.368 | 40.572 | 10.457 | 13.467 | 4.119 | 9.795 | 6.145 | 9.12 | 2.098 | 4.808 | 3.243 | 5.261 | 1.167 | 0.081 | 0.19 | 2.528 | 3.62 | 7.1 |
| Gross Profit Ratio
| -3.211 | 0.464 | -1.666 | -11.717 | -20.405 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0.935 | 0.962 | 1 | 1 | 1 | 0.568 | 0.713 | 0.855 |
| Reseach & Development Expenses
| 88.477 | 187.651 | 249.24 | 94.245 | 88.017 | 95.258 | 98.573 | 88.712 | 57.792 | 34.095 | 21.369 | 17.985 | 20.032 | 13.257 | 9.408 | 5.75 | 9.626 | 8.51 | 11.455 | 6.549 | 2.147 | 2.466 | 0.46 | 6.977 | 8.1 |
| General & Administrative Expenses
| 47.582 | 90.185 | 53.752 | 37.248 | 27.203 | 29.315 | 28.29 | 23.892 | 18.064 | 15.858 | 13.643 | 10.778 | 11.989 | 12.108 | 13.669 | 10.006 | 11.08 | 8.08 | 5.981 | 6.129 | 4.567 | 3.658 | 0 | 5.611 | 0 |
| Selling & Marketing Expenses
| -3.504 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 44.079 | 90.185 | 53.752 | 37.248 | 27.203 | 29.315 | 28.29 | 23.892 | 18.064 | 15.858 | 13.643 | 10.778 | 11.989 | 12.108 | 13.669 | 10.006 | 11.08 | 8.08 | 5.981 | 6.129 | 4.567 | 3.658 | 6.623 | 5.611 | 5.5 |
| Other Expenses
| -4.712 | -3.862 | 0.343 | 3.416 | 0.496 | 0.361 | 0.807 | 0.128 | 0.178 | 0.348 | -45.633 | 1.983 | 0 | 0 | 9.282 | 4,672,527 | 7,547,578 | 0.225 | 0.206 | 5.603 | 2.072 | 2.282 | 0 | 0.566 | 0.4 |
| Operating Expenses
| 132.555 | 277.836 | 302.993 | 131.493 | 115.22 | 124.573 | 126.863 | 112.604 | 75.856 | 49.953 | 35.012 | 28.763 | 32.021 | 25.365 | 23.078 | 15.756 | 20.706 | 16.814 | 17.642 | 12.678 | 6.714 | 6.124 | 7.083 | 13.154 | 14 |
| Operating Income
| -135.227 | -267.574 | -301.218 | -124.082 | -111.109 | -94.091 | -83.643 | -76.236 | -34.284 | -39.496 | -19.544 | -23.494 | -21.639 | -19.22 | -13.958 | -13.658 | -15.898 | -13.346 | -15.507 | -11.511 | -6.633 | -5.935 | -5.576 | -9.535 | -6.9 |
| Operating Income Ratio
| -162.53 | -26.074 | -169.723 | -16.742 | -27.021 | -3.087 | -1.981 | -2.155 | -0.845 | -3.777 | -1.451 | -5.704 | -2.209 | -3.128 | -1.53 | -6.511 | -3.307 | -3.848 | -2.836 | -9.863 | -82.371 | -31.315 | -1.252 | -1.878 | -0.831 |
| Total Other Income Expenses Net
| 0.109 | -10.079 | -2.006 | -38.808 | -9.701 | -1.628 | -5.176 | 2.238 | 3.778 | 3.024 | -44.671 | 4.765 | 9.278 | 1.507 | -10.503 | 0.049 | 3.422 | -1.139 | -3.33 | 11.511 | 6.633 | 0.027 | -3.29 | -0.597 | 0.3 |
| Income Before Tax
| -135.117 | -277.653 | -303.224 | -162.89 | -120.809 | -94.798 | -88.206 | -73.74 | -31.201 | -36.14 | -66.084 | -19.713 | -12.948 | -17.713 | -24.461 | -13.609 | -12.477 | -14.485 | -15.505 | -0 | -0 | -5.908 | -8.866 | -10.132 | -6.6 |
| Income Before Tax Ratio
| -162.399 | -27.056 | -170.854 | -21.979 | -29.38 | -3.11 | -2.089 | -2.085 | -0.769 | -3.456 | -4.907 | -4.786 | -1.322 | -2.883 | -2.682 | -6.488 | -2.595 | -4.176 | -2.836 | -0 | -0 | -31.174 | -1.991 | -1.995 | -0.795 |
| Income Tax Expense
| 0 | 10.011 | 2.161 | 52.196 | -0.257 | 2.17 | 1.756 | -4.623 | -2.098 | -3.722 | 88.117 | -8.109 | -16.285 | -4.083 | 11.713 | -0.742 | -8.116 | -0.867 | 6.451 | -0.538 | -1.989 | 0.057 | 0 | 0.638 | -0.6 |
| Net Income
| -135.117 | -287.664 | -305.385 | -215.086 | -120.552 | -96.968 | -88.206 | -73.74 | -29.188 | -36.122 | -66.028 | -19.669 | -15.253 | -17.614 | -24.411 | -12.966 | -11.204 | -12.479 | -15.297 | -10.973 | -4.665 | -5.965 | -8.866 | -9.6 | -6.6 |
| Net Income Ratio
| -162.399 | -28.031 | -172.071 | -29.022 | -29.318 | -3.181 | -2.089 | -2.085 | -0.719 | -3.454 | -4.903 | -4.776 | -1.557 | -2.866 | -2.677 | -6.181 | -2.331 | -3.598 | -2.798 | -9.402 | -57.928 | -31.473 | -1.991 | -1.891 | -0.795 |
| EPS
| -6.09 | -14.47 | -17.55 | -16.64 | -14.65 | -1.05 | -1.08 | -1.01 | -0.43 | -0.61 | -1.43 | -0.58 | -0.48 | -0.68 | -1.31 | -1.18 | -1.08 | -1.58 | -3.22 | -2.49 | -1.4 | -2.35 | -5.13 | -6.8 | -5.21 |
| EPS Diluted
| -6.09 | -14.47 | -17.55 | -16.64 | -14.65 | -1.05 | -1.08 | -1.01 | -0.43 | -0.61 | -1.43 | -0.58 | -0.48 | -0.68 | -1.31 | -1.18 | -1.08 | -1.58 | -3.22 | -2.49 | -1.4 | -2.35 | -5.13 | -6.8 | -5.21 |
| EBITDA
| -131.723 | -268.553 | -293.334 | -76.17 | -105.58 | -89.455 | -82.981 | -75.278 | -34.543 | -38.275 | 24.188 | -25.783 | -29.491 | -19.588 | -11.022 | -12.714 | -18.365 | -12.435 | -8.046 | -10.938 | -6.049 | -5.283 | -5.576 | -8.371 | -6.8 |
| EBITDA Ratio
| -158.319 | -26.169 | -165.281 | -10.278 | -25.677 | -2.935 | -1.965 | -2.128 | -0.851 | -3.66 | 1.796 | -6.26 | -3.011 | -3.188 | -1.209 | -6.061 | -3.82 | -3.585 | -1.472 | -9.372 | -75.114 | -27.877 | -1.252 | -1.649 | -0.819 |